James Lovell
Interventional Cardiology · West Des Moines, IANPI 1386639060
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 97.8% of the total across 37 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 11 manufacturers reported payments, led by Abbott at 46.4% of the total. That places this record below the midpoint for interventional cardiology clinicians in IA, where the typical reported total is $3,872.
Across 37 payments — averaging $17.11 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$294
- Medtronic$90
- Boehringer Ingelheim$70
- Pfizer$46
- Novartis$39
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$23
- plus $73 from 5 others
Across 151 payments — averaging $1619.85 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Kowa Research Institute, Inc.$90K
- Novartis$76K
- Esperion Therapeutics, Inc.$60K
- Abbott$18K
What the payments were for
- Food & beverage$61998%
- Education$142%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 19 | $294 |
| Medtronic(2 entities) | 4 | $90 |
| Boehringer Ingelheim | 1 | $70 |
| Pfizer | 3 | $46 |
| Novartis | 3 | $39 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 2 | $23 |
| Cardiovascular Systems Inc. | 1 | $16 |
| Chiesi USA, Inc. | 1 | $16 |
| Teleflex LLC | 1 | $14 |
| AstraZeneca | 1 | $14 |
| Johnson & Johnson | 1 | $13 |
How this compares
$633 in reported general payments places this provider in the 15th percentile of 64 interventional cardiology providers in Iowa.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Metoprolol Succinate | 11 | $234 |
Paid to pharmacies, not to this prescriber.
Other interventional cardiology in West Des Moines
- Magdi GhaliWest Des Moines$64K
- Mark TannenbaumWest Des Moines$2K
- Michael FraizerWest Des Moines$1K
- Liberato IannoneWest Des Moines$1K
- Nicolas ShammasDavenport$808K
- Eric DippelDavenport$100K
- Atul ChawlaDes Moines$78K
- David McAllisterDes Moines$55K
- Daniel ShivapourDes Moines$54K
- Srikanth KasulaDavenport$43K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.